Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Cohance Lifesciences Ltd

NSE: COHANCE · BSE: 543064 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹456.65
Market cap
₹17,471 Cr
Revenue (annual)
₹2,269 Cr
Net profit (annual)
₹179.2 Cr
P/E (TTM)
164.5×Sector 47.4×
Promoter holding
57.49%+0.00% QoQ
FII holding
6.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:35 IST BSE
Credit Rating

Cohance Lifesciences Credit Rating

Cohance Lifesciences has withdrawn its credit ratings from CRISIL Ratings Limited for certain loan facilities. The company continues to maintain valid ratings from India Ratings.

Value
₹72.50 Cr